Wednesday, August 10, 2022


Vimla Black-Gupta Is Appointed CEO of GLO Pharma

Former Estee Lauder and Procter & Gamble Beauty Executive

Latest Posts

New Study Highlights Superior Efficacy of At-home Dry EEG assessment Compared to Lab-based Monitoring

Results indicate that easy-to-use task-driven EEG can yield clinical-grade data in large-scale, real-world investigations in neuroscience with extremely high adherence rates.

Gamida Cell Announces Dosing of First Patient in Company-Sponsored Phase 1/2 Study of NK Cell Therapy Candidate GDA-201

“We are excited to further advance the development of GDA-201, a NAM-enabled natural killer (NK) cell therapy candidate which we believe has the potential to be a new readily available, cryopreserved treatment option for cancer patients with relapsed/refractory lymphoma,” said Ronit Simantov, M.D., chief medical and scientific officer of Gamida Cell.

Akadeum Life Sciences Announces New Dead Cell Removal Kit Using Microbubble Technology

Akadeum Life Sciences advises that the new buoyant separation method creates a more effective way for researchers to use valuable samples with a higher retention rate of viable cells than current magnetic techniques.

Bio-Rad Extends Range of StarBright Violet and UltraViolet Dyes for Multiplex Flow Cytometry

StarBright Violet 760, StarBright UltraViolet 575, and StarBright UltraViolet 605 dyes conjugated to highly validated antibodies for multicolor panel design in immunology research.

GLO Pharma, the parent company of breakthrough subtopical skincare brand Ourself, today announces the promotion of Vimla Black-Gupta to CEO of Ourself.

Vimla Black-Gupta, a co-founder of Ourself, currently serves as the brand’s President and sits on the board of GLO Pharma.

Ms. Black-Gupta is a seasoned beauty executive who brings over 25 years of leadership experience and business acumen to her newly expanded role as CEO. A former executive at The Estee Lauder Companies, Procter & Gamble, and Equinox, Ms. Black-Gupta’s entrepreneurial spirit drew her back into the startup world when she saw and seized the opportunity to create an entirely new category in the beauty market with Ourself, bridging the gap between traditional topicals and aesthetic procedures.

After beginning as CMO a mere 15 months ago, Ms. Black-Gupta was instrumental in driving Ourself’s go-to-market strategy and quickly captured consumer attention when the brand debuted in February 2022. She was able to understand and capitalize on the uniqueness of the brand’s technology platform and subsequent hero products, including the brand’s Lip Filler, which, as a result, has already sold out multiple times.

As president, she has been and continues to be instrumental in assembling an impressively credentialed Board of Directors for GLO Pharma and raising venture capital for Ourself, which is backed by over $40M in funding to date. Now, as CEO, Ms. Black-Gupta has plans to accelerate the brand into its next phase of high growth. This includes driving significant product expansion into new categories, with a solid roadmap of innovation on deck through 2024, and an aggressive retail strategy to further distribution.

“After spending 25 years in the beauty and wellness industry, I know firsthand that we are overdue for a revolution in skincare, and it’s finally here,” said Ms. Black-Gupta. “Ourself is defining a new category at the intersection of medical aesthetics and luxury skincare, with non-invasive technology that is easy to self administer at home. I am thrilled to be leading a brand that finally enables consumers to look and feel like the selves they love the most.”

Prior to joining GLO Pharma and Ourself, Ms. Black-Gupta served as Chief Marketing Officer of Equinox, where she oversaw the company’s global marketing strategy and developed unique campaigns that elevated its positioning.

Prior, Vimla Black-Gupta spent 10 years at The Estee Lauder Companies and held the position of Senior Vice President of Global Marketing at Bobbi Brown Cosmetics. There, she led product development and consumer and digital marketing strategy, growing the brand to a $1B business across 150 countries. She also spent a decade at Procter & Gamble, where she oversaw the strategic positioning and new product and category development for Gillette’s Venus brand as Global Marketing Director.

Latest Posts

Learn More




Our Sister Publication

Medical Device News Magazine